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Letter to the Editor
Novel mutations in the pejvakin gene
are associated with autosomal recessive
non-syndromic hearing loss in
Iranian families
To the Editor:
Hearing loss is a very heterogeneous disorder
and may be due to genetic or environmental
causes, or both. The incidence of pre-lingual
deafness is about 1 in 1000 neonates of which
more than 60% of cases are inherited (1–3).
About 80% of hereditary deafness cases are non-
syndromic and the major mode of inheritance is
autosomal recessive (4). A novel gene, DFNB59
encoding pejvakin located on chromosome
2q31.2, has been very recently shown to cause
neural deafness in four Iranian families. The
pejvakin gene is predicted to encode a poly-
peptide of 352 amino acids containing a nuclear
localization signal in residues 249–258 and zinc-
binding motif in residues 305–331 (5).
Here, we report mutation analysis for DFNB59
gene in 30 autosomal recessive non-syndromic
hearing loss (ARNSHL) families, with an aver-
age of five deaf individuals in each family, which
also originate from six provinces of Iran.
Thirteen families from Chaharmahal va Bakhtiari
(southwest), five families from Gilan (north),
four families from Khoozestan (southwest), three
families from Azerbaijan sharqi (northwest),
three families from Kordestan (west) and two
families from Tehran (central) were studied. All
samples had been previously excluded for muta-
tions in the GJB2 gene (6–11). All patients were
clinically characterized and examined for pure-
tone audiometry and were found to have mild to
profound sensorineural hearing loss. Informed
consent was obtained from all subjects or parents
of underaged patients.
The DFNB59 gene consists of seven exons, in
which the first exon is non-coding. The entire
coding region of the DFNB59 gene was poly-
merase chain reaction amplified and directly
sequenced. The resultant sequences were com-
pared with reference sequence NM_001042702
using SEQSCAPE V2.0 software. To date, only two
pathogenic mutations (T54I and R183W) in four
pedigrees of a cohort of Iranian consanguineous
families have previously been reported (5) and the
presence of DFNB59 sequence variations in other
populations is not yet known. In the current
study, five additional DFNB59 sequence varia-
tions were identified including two frameshift
(c.726delT and c.988delG) and three missense
(c.793C.T, c.793C.G and c.874G.A) changes
(Table 1, Fig. 1d). Our data indicated that two
novel variants (c.726delT and c.988delG), which
are predicted to lead to premature termination at
codons 248 and 336, respectively, co-segregate
with the severe to profound disease phenotype
(Fig. 1a–c) and are not found in 100 control
Table 1. DFNB59 sequence variations identified in Iranian deaf families and hearing controls. All novel sequence variations
were named following the nomenclature recommendations (17). The frequency of the sequence variations (c.726delT and
c.988delG) in the control population was determined using restriction endonuclease digestion of exon 6 (the mutation c.726delT
creates a BsrDI restriction site) and direct sequencing of exon 7 of the DFNB59 gene, respectively
Amino acid
changes
Nucleotide
changes
Number of
chromosomes
Number of
families
Type of
variations
Number of controls
(n ¼ 100)
p.F242LfsX7 c.726delT 2 1 Frameshift 0
p.R265C c.793C.T 3 3 Missense 6
p.R265G c.793C.G 4 4 Missense 17
p.G292R c.874G.A 2 1 Missense 1
p.V330LfsX7 c.988delG 2 1 Frameshift 0
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subjects, suggesting a pathogenic role of the
abovementioned variations. Another novel mis-
sense substitution (c.874G.A) does not occur in
a conserved amino acid and does not co-segregate
with deafness (data not shown). This change was
also found in 1/100 control individuals, suggesting
that it is most likely to represent a rare poly-
morphism and not a pathogenic variation (12–14).
The changes involving nucleotide 793 represent
known polymorphisms.
Auditory neuropathy is a sensorineural disor-
der identified by normal otoacoustic emissions
(OAEs), but absent or abnormal auditory brain-
stem responses (ABR). The audiological evalua-
tion of family b’ (V-5, V-9 and V-12) showed
absent ABR with no OAEs (data not shown),
which strongly suggests hearing loss of cochlear
origin (15). These findings do not meet the
diagnostic criteria for auditory neuropathy (5),
indicating different audiological manifestation of
DFNB59 gene mutations.
Our previous studies indicate that mutation of
GJB2 gene accounts for 18.29% of ARNSHL
families in Iran (16). While the frequency of
DFNB59 mutation in other populations remains
to be determined, our data represented here indicate
an importantassociationof this genewithARNSHL
in Iran and suggest that it is likely to account for
disease in6.7% of GJB2-negative families.
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